Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes

The in vitro action of interferon (IFN)-α and IFN-γ from six healthy donors and ten patients with multiple sclerosis (MS) on natural killer (INK) activity of peripheral blood lymphocytes (PBL) was studied in an autologous system. The NK activity of PBL was detected by a cytotoxic test using 3H-uridi...

Full description

Saved in:
Bibliographic Details
Main Authors: S. B. Cheknev, Y. G. Ashmanova, A. D. Pritsker, O. L. Latysheva, F. I. Yershov, A. J. Kulberg
Format: Article
Language:English
Published: Wiley 1994-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/S0962935194000475
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550566831587328
author S. B. Cheknev
Y. G. Ashmanova
A. D. Pritsker
O. L. Latysheva
F. I. Yershov
A. J. Kulberg
author_facet S. B. Cheknev
Y. G. Ashmanova
A. D. Pritsker
O. L. Latysheva
F. I. Yershov
A. J. Kulberg
author_sort S. B. Cheknev
collection DOAJ
description The in vitro action of interferon (IFN)-α and IFN-γ from six healthy donors and ten patients with multiple sclerosis (MS) on natural killer (INK) activity of peripheral blood lymphocytes (PBL) was studied in an autologous system. The NK activity of PBL was detected by a cytotoxic test using 3H-uridine human erythromyeloblast K562 cells. Autologous IFN-α and IFN-γ did not augment NK activity of PBL from healthy donors in vitro, whereas in samples from MS patients the IFNs strongly stimulated NK cell cytotoxic function. This stimulation suggests the existence of an inhibitor of regulatory IFN action, that is produced in healthy donors simultaneously with IFN in response to IFN induction, but which is lacking in commercial IFN preparations. The factor-containing supernatants from healthy donors reduced the stimulatory action of autologous IFNs in patients with MS almost until complete blockade. Because this inhibitor was absent in patients with MS, deficiency of an inhibitor of IFN regulatory action in MS could open the way to treatment of this compartment of the immune system.
format Article
id doaj-art-7afe415fd51c497297a7c5dcd470018c
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 1994-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-7afe415fd51c497297a7c5dcd470018c2025-02-03T06:06:25ZengWileyMediators of Inflammation0962-93511466-18611994-01-013534134610.1155/S0962935194000475Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood LymphocytesS. B. Cheknev0Y. G. Ashmanova1A. D. Pritsker2O. L. Latysheva3F. I. Yershov4A. J. Kulberg5Laboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaLaboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaLaboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaLaboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaLaboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaLaboratory of Immunochemistry and Department of Interferons, N. F. Gamaleya Institute for Epidemiology and Microbiology of the Russian Academy of Medical Sciences, Moscow 123098, RussiaThe in vitro action of interferon (IFN)-α and IFN-γ from six healthy donors and ten patients with multiple sclerosis (MS) on natural killer (INK) activity of peripheral blood lymphocytes (PBL) was studied in an autologous system. The NK activity of PBL was detected by a cytotoxic test using 3H-uridine human erythromyeloblast K562 cells. Autologous IFN-α and IFN-γ did not augment NK activity of PBL from healthy donors in vitro, whereas in samples from MS patients the IFNs strongly stimulated NK cell cytotoxic function. This stimulation suggests the existence of an inhibitor of regulatory IFN action, that is produced in healthy donors simultaneously with IFN in response to IFN induction, but which is lacking in commercial IFN preparations. The factor-containing supernatants from healthy donors reduced the stimulatory action of autologous IFNs in patients with MS almost until complete blockade. Because this inhibitor was absent in patients with MS, deficiency of an inhibitor of IFN regulatory action in MS could open the way to treatment of this compartment of the immune system.http://dx.doi.org/10.1155/S0962935194000475
spellingShingle S. B. Cheknev
Y. G. Ashmanova
A. D. Pritsker
O. L. Latysheva
F. I. Yershov
A. J. Kulberg
Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
Mediators of Inflammation
title Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
title_full Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
title_fullStr Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
title_full_unstemmed Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
title_short Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
title_sort autologous enhancement by interferon of natural killer activity of human peripheral blood lymphocytes
url http://dx.doi.org/10.1155/S0962935194000475
work_keys_str_mv AT sbcheknev autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes
AT ygashmanova autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes
AT adpritsker autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes
AT ollatysheva autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes
AT fiyershov autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes
AT ajkulberg autologousenhancementbyinterferonofnaturalkilleractivityofhumanperipheralbloodlymphocytes